Savara Inc
Stock Chart, Company Information, and Scan Results
$5.50(as of Jun 18, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Savara Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$5.50
Ticker SymbolSVRA
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees70
CountyUSA
Market Cap$1,127.1M
EBIDTA-133.2M
P/E Ratio-10.76
Forward P/E Ratio0.41
Earnings per Share-0.56
Profit Margin-Infinity%
RSI60.39
Shares Outstanding204.9M
ATR0.27
52-Week High7.01
Volume4,761,500
52-Week Low1.98
Book Value176.0M
P/B Ratio7.91
Upper Keltner5.79
P/S RatioInfinity
Lower Keltner4.60
Next Earnings Date08/11/2026
Cash Surplus23.3M
Next Ex-Dividend DateUnknown
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. was founded in 2007 and is headquartered in Langhorne, Pennsylvania.
Savara Inc In Our Stock Scanner
As of Jun 22, 2026
Scan Name: Cup and HandleScan Type: Chart Pattern Scans
As of ---
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.